Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      International Patient Advocacy Groups Mark "World Scleroderma Day," June 29

      Global Observances and Outreach Bring Attention to Complex, Debilitating Autoimmune Disease


      News provided by

      Scleroderma Foundation

      Jun 24, 2013, 02:16 ET

      Share this article

      Share this article


      TOURNAI, Belgium, HAMILTON, Ontario, and DANVERS, Mass., June 24, 2013 /PRNewswire-USNewswire/ -- An international consortium of patient advocacy groups dealing with the autoimmune disease scleroderma, also called systemic sclerosis, will mark World Scleroderma Day on Saturday, June 29. Events and observances around the world will be held and are designed to foster greater awareness and understanding of this little-known disease. Scleroderma, which can strike women, men and children, is a complex, debilitating – and sometimes fatal – degeneration of the body's organ and vascular systems.

      The Federation of European Scleroderma Associations (FESCA), consisting of 23 independent, national European organizations, The Scleroderma Society of Canada, and the Scleroderma Foundation in the United States, are working cooperatively to raise awareness about scleroderma. The groups encourage the international scleroderma community to reach out to media, government officials, and the medical community on and around World Scleroderma Day.

      June has been observed as "Scleroderma Awareness Month" since the 1980s in the U.S. and several Canadian provinces, with proclamations issued from national, state and provincial governments. The first World Scleroderma Day was inaugurated in Europe on June 29, 2009. In February 2010, the first Systemic Sclerosis World Congress was held in Florence, Italy, where it was officially decided that June 29 would be recognized as World Scleroderma Day.  Within the past three years, the day has grown to include observances in Australia, Brazil, Canada, Europe, India, the U.S., and many more countries.

      About Scleroderma (Systemic Sclerosis)

      Scleroderma, or systemic sclerosis, is a chronic systemic autoimmune disease characterized by the over-production of collagen, creating fibrosis of the skin and internal organ systems. The word "scleroderma" comes from two Greek words, "sclero" meaning hard, and "derma" meaning skin. Hardening of the skin is one of the most visible manifestations of the disease.

      There are two major classifications of scleroderma: localized scleroderma and systemic sclerosis. Other forms or sub-classifications, each with its own characteristics and prognosis, may be identified through future research.

      Scleroderma symptoms vary greatly for each person, and the effects of the disease can range from mild to life-threatening, depending on which parts of the body are affected and the extent to which they are affected. Prompt and proper diagnosis and treatment by qualified physicians may minimize the symptoms of scleroderma and lessen the chance for permanent damage.

      As in most autoimmune diseases, women are disproportionately affected by scleroderma. Overall, female patients outnumber male patients by approximately 4-to-1.  Scleroderma can develop in every age group from infants to the elderly, but its onset is most frequent between the ages of 25 to 55.

      Beyond gender, other factors, such as race and ethnic background, may influence the risk of developing scleroderma, the age of onset, and the pattern or severity of internal organ involvement. The reasons for this are not clear. Although scleroderma is not directly inherited, some scientists feel there is a slight predisposition to it in families with a history of rheumatic disease.

      Currently, there is no cure for scleroderma, but there are many treatments available to help particular symptoms. Because scleroderma can affect numerous organ systems, there is considerable variation in the treatments based on an individual's particular disease manifestation.

      Why World Scleroderma Day is Important

      Like many individuals who face life with the complications associated with a little-known or rare disease, those living with scleroderma often feel isolated, alone, and misunderstood as their life and physical abilities change due to the effects of the disease. Beyond the social and emotional impacts of scleroderma, knowledge of the disease among the medical community often is lacking. This leads to inaccurate diagnosis, and a prolonged period before an accurate diagnosis is made, thus resulting in a lack of proper medical intervention during early onset of disease. World Scleroderma Day was created to empower patients and generate greater understanding and recognition of the disease.

      "Awareness is at the core of our mission," said Ann Tyrrell Kennedy, the president of FESCA who resides in France. "By joining together on a global level, the collective voice of the scleroderma community can be heard more loudly and frequently, which can lead to greater interest in this disease."

      Other scleroderma organization leaders agree. Robert J. Riggs, Chief Executive Officer of the U.S.-based Scleroderma Foundation commented, "In the United States, approximately 300,000 people have scleroderma, but recent studies indicate that the overall annual direct and indirect costs of the disease in the U.S. are $1.5 billion, with a direct cost of treatment for patients reaching $460 million annually. Yet, in the U.S., the federal investment in scleroderma research reaches only about $20 million each year. When you look at those numbers," Riggs said, "one realizes that scleroderma is not only a devastating disease, but also one that carries a significant economic impact.  Clearly more needs to be done to find the cause, better treatments and hopefully a cure."

      "World Scleroderma Day brings focus on this disease at a critical time in global research initiatives," said Maureen Sauve, president of the Scleroderma Society of Canada. "It's exciting to see researchers working in this field fostering greater collaborations across institutions and international borders to advance science in search of treatments and a cure."  All three leaders agree that momentum for scleroderma research has increased over the past seven to 10 years, including more significant findings than there have been in previous decades. "Like most diseases, scleroderma is a global problem, and solutions will come when we work as a global community, which is the goal of World Scleroderma Day," commented Tyrrell Kennedy.

      Upcoming Research and Education Events

      Numerous national and international meetings are forthcoming in the months ahead that generate scleroderma awareness and education.  Key meetings and congresses include:

      July 26 – 28, 2013, Atlanta, GA., USA:  15th Annual Scleroderma Foundation Patient Education Conference, www.scleroderma.org

      July 27, 2013, Atlanta, GA., USA: Scleroderma Foundation Continuing Medical Education/Continuing Nurse Education Sessions, "The Lung in Scleroderma," www.scleroderma.org

      August 3 – 7, 2013, Boston, Mass., USA: 13th International Workshop on Scleroderma Research, www.bumc.bu.edu/sclerodermaworkshop

      September 27 – 28, 2013, Hamilton, Ontario, Canada: 2013 Scleroderma Canada Congress, www.sclerodermacongress.ca

      February 6 – 8, 2014, Rome, Italy:  3rd Systemic Sclerosis World Congress, www.fesca-scleroderma.eu/upcoming-events/3rd-systemic-sclerosis-world-congress-2014

      For More Information

      To learn more about scleroderma and events surrounding World Scleroderma Day, please visit the following:

      In the European Union:
      Federation of European Scleroderma Associations (FESCA)
      www.fesca-scleroderma.eu

      In Canada:
      Scleroderma Society of Canada
      +1-866-279-0632
      www.scleroderma.ca

      In the United States:
      Scleroderma Foundation, Inc.
      +1-800-722-4673
      www.scleroderma.org

      Media Contacts:

      European Union: Ann Tyrrell Kennedy: [email protected]
      Canada: Maureen Sauve: [email protected]
      United States: Christina Relacion: [email protected]

      SOURCE Scleroderma Foundation

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.